One of the most touted promises of medical artificial intelligence tools is their ability to augment human clinicians’ performance by helping them interpret images such as X-rays and CT scans with greater precision to make more accurate diagnoses.
Viking’s GLP-1/GIP receptor agonist helped patients lose almost 15% of their body weight over 13 weeks
Viking Therapeutics’ dual GLP-1/GIP receptor agonist for obesity showed off positive topline data from a Phase II study, with analysts describing the drug as a
February 28, 2024